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ABSTRACT
Introduction Domestic violence and abuse (DVA) is 
prevalent, harmful and more dangerous among diaspora 
communities because of the difficulty accessing DVA 
services, language and migration issues. Consequently, 
migrant/refugee women are common among primary 
care populations, but evidence for culturally competent 
DVA primary care practice is negligible. This pragmatic 
cluster randomised controlled trial aims to increase DVA 
identification and referral (primary outcomes) threefold 
and safety planning (secondary outcome) among diverse 
women attending intervention vs comparison primary care 
clinics. Additionally, the study plans to improve recording 
of DVA, ethnicity, and conduct process and economic 
evaluations.
Methods and analysis Recruitment of ≤28 primary 
care clinics in Melbourne, Australia with high migrant/
refugee communities. Eligible clinics need ≥1 South 
Asian general practitioner (GP) and one of two common 
software programmes to enable aggregated routine data 
extraction by GrHanite. Intervention staff undertake three 
DVA training sessions from a GP educator and bilingual 
DVA advocate/educator. Following training, clinic staff and 
DVA affected women 18+ will be supported for 12 months 
by the advocate/educator. Comparison clinics are trained 
in ethnicity and DVA data entry and offer routine DVA 
care. Data extraction of DV identification, safety planning 
and referral from routine GP data in both arms. Adjusted 
regression analysis by intention- to- treat by staff blinded to 
arm. Economic evaluation will estimate cost- effectiveness 
and cost–utility. Process evaluation interviews and analysis 
with primary care staff and women will be framed by 
Normalisation Process Theory to maximise understanding 
of sustainability. Harmony will be the first primary care trial 
to test a culturally competent model for the care of diverse 
women experiencing DVA.
Ethics and dissemination Ethical approval from La 
Trobe University Human Ethics Committee (HEC18413) 
and dissemination by policy briefs, journal articles and 
conference and community presentations.
Trial registration number ANZCTR- 
ACTRN12618001845224; Pre- results.
INTRODUCTION
Domestic violence and abuse (DVA), espe-
cially intimate partner violence (IPV) affects 
at least one in three women globally and 
one in six Australian women.1 2 It can be 
defined as behaviour by an intimate partner 
or ex- partner that causes physical, sexual 
Strengths and limitations of this study
 ► First domestic violence and abuse (DVA) study 
specifically co- designed with ethno- specific DVA 
agencies and communities and piloted for culturally 
competent practice in primary care.
 ► Based on three previous successful DVA trials in pri-
mary care, with one intervention (Identification and 
Response to Improve Safety) being scaled up across 
the UK, one intervention (WEAVE) being rolled out 
across Australia and MOSAIC (Mothers’ Advocates in 
the Community) planned for rollout in Peru.
 ► All general practitioner clinics (in both arms) trained 
for improved and easier recording of domestic vi-
olence and ethnicity in routine computer software.
 ► Currently, no rigorous way to accurately identify mi-
grant/refugee patients in primary care.
 ► Recruitment and practice is affected by the 
COVID-19 epidemic.
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or psychological harm, including aggression, sexual 
coercion and psychological abuse and controlling 
behaviours.3 While IPV is the most common form of 
DVA, other family members, for example, in- laws, can 
significantly contribute to the abuse. DVA has a particu-
larly damaging effect on women’s mental as well as phys-
ical and reproductive health.1 Women victim survivors 
experience higher rates of health problems, compared 
with non- affected women, including: physical injuries, 
chronic pain, post- traumatic stress disorder (PTSD), 
depression and anxiety, unplanned pregnancies, gynae-
cological trauma and death.4 In 2014–2015, almost two 
Australian women a week were murdered by an intimate 
partner.5
Australia is a culturally and linguistically diverse society 
with 28% of the population born overseas and almost 
50% from a migrant or refugee background.6 Migrant 
and refugee families are often impacted by a multitude 
of intersectional barriers that impact their experience, 
particularly of DVA.7 They can face significant hurdles 
to good mental health and safety—racism, lack of knowl-
edge about Australian systems and services, and the 
broader challenges of acculturation. Furthermore, rigid 
cultural norms, stereotyped gender roles, visa limitations 
and fear of authorities can impact on migrant and refugee 
community’s ability to engage with service providers.8
In countries where war or social upheaval has recently 
taken place; few sanctions against DVA exist; and where 
women have no access to sanctuary, either as refuge or 
family support, rates of DVA are high.9 Such countries, 
including South Asia (SA) countries, represent signifi-
cant diaspora communities, especially those with young 
families. Women in these countries report poorer mental 
health, obstetric and child health outcomes than the non- 
abused women in their countries.10 11
Risk factors and approaches to DVA among diaspora 
communities
Surveys of DVA among diaspora communities are few. 
While none have random samples and use differing 
samples and measurement tools, some have found similar 
DVA rates to those in countries of origin.8 12 Common 
risks for IPV include low education and employment 
status and perpetrator alcohol abuse, but migrant and 
refugee women experience additional risks with poor 
knowledge of rights and services.13 14 An effective and 
acknowledged strategy to reach victims and families is the 
use of bicultural workers.15
In Victoria, Australia, women from SA (India, Pakistan, 
Bangladesh, Nepal and Sri Lanka) comprise the largest 
group of migrants with young families and are dispro-
portionately represented in DVA agency data.16 With 
the resulting social isolation, combined with little or no 
knowledge of available supports, language barriers and 
different cultural norms, migrant and refugee women 
experiencing DVA can be at great risk of serious harm 
and femicide.17 18
Domestic violence and interventions in primary care
Due to greater ill health, victims and their children are 
over- represented in clinical settings compared with the 
general community.19 There is a dearth of evidence for 
effective DVA interventions in primary care settings.20 
No DVA intervention studies in primary care have specif-
ically addressed the cultural competency of clinicians. 
Primary healthcare providers are often the only contact 
with a healthcare professional for a woman who is experi-
encing DVA.19 It is common for symptoms of abuse to go 
unrecognised by healthcare providers.20 Primary health-
care providers are uniquely placed to identify DVA and 
provide support.
Evidence for effective primary healthcare interventions and 
expert DVA advocacy
HARMONY has been adapted from three cluster 
randomised controlled trials of DVA in general prac-
tices19 21 22 but drew most heavily in design from the IRIS 
(Identification and Response to Improve Safety) study, 
the approach of which is described in detail below. We 
enhanced the IRIS model with understanding about 
primary care cultural competency23 and with parts of the 
WEAVE intervention model.19 The WEAVE trial incor-
porated brief motivational counselling for women at 
different levels of readiness that reduced depression and 
increased general practitioner (GP) safety discussions.19 
We felt that migrant/refugee women would require GP 
support to build confidence and discuss safety before they 
are ready to act on a referral.
We built on GP DVA training from all three trials.18, 
20,22
The IRIS general practice systems model
IRIS is a system- level GP DVA intervention in the UK.21 
IRIS aimed to improve DVA identification, documenta-
tion and management in primary care and referral rates 
to specialist DVA agencies. It consisted of joint training for 
all clinicians by GP trainers and advocates, and sustained 
support from an advocate. Advocates supported women 
who experienced DVA and aimed to empower them, 
increase their safety and link them and their children to 
community support services. The trial showed a three-
fold increase for documented disclosures risk ratio (RR) 
3.1 (95% CI 2.2 to 4.3) and sixfold for referrals RR 6.43 
(95% CI 4.15 to 9.97) documented by specialist agencies 
compared with clinics offering usual care.
Patient and public involvement
No patient involved.
Feasibility study
HARMONY was developed in consultation with migrant/
refugee non- government organisations (NGOs) and 
communities.
It was piloted in 2015 for 4 months with two interven-
tion and two comparison clinics in north- west metropol-
itan Melbourne. The feasibility study successfully trialled 
recruitment, DVA culturally competent training and the 
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use of GrHanite, a specially designed GP data software 
programme. To date, there has been no way to routinely 
monitor trends in identification nor any form of DVA GP 
management in Australia. The University of Melbourne 
has developed GrHanite, a software tool designed to 
extract data ethically for research with a specific capability 
to interface with the majority of GP computer systems in 
use in Australia. HARMONY has developed and is further 
testing GrHanite for routine DVA and ethnicity data 
collection.
Pilot study results (unpublished) demonstrated 
HARMONY effectiveness, with 13 referrals to In Touch 
(Multicultural agency against family violence (FV)) from 
the intervention clinics compared with 0 in the compar-
ison clinics. These results were sufficiently encouraging 
to lead to this more rigorous study.
Study design, aims and objectives
HARMONY is designed as a pragmatic (parallel group) 
cluster- randomised controlled trial with GP clinics as the 
units of cluster and no stopping rules. HARMONY will 
test a GP clinic system intervention (IRIS) for effective-
ness in Australian primary care.
Specifically, HARMONY aims primarily to (1) Increase 
(A) GP identification and (B) referral of DVA among 
all women aged 18+ in intervention versus comparison 
clinics.
This will be measured (A) by extracting routine GP 
data on identification and referrals, and (B) compared 
with referrals received by InTouch Multicultural Centre 
for Family Violence in both arms. We will explore the rate 
among migrant/refugee (especially South Asian women).
HARMONY’s secondary aims are to (2) Increase GP 
safety planning for DVA among women aged 18+ in inter-
vention compared with comparison clinics. This will be 
measured by extracting routine GP data. We will explore 
the rate among migrant/refugee (especially South Asian 
women); (3) Determine the cost- effectiveness of the 
intervention relative to usual care and (4) Investigate the 
factors that enable practice change and sustainability.
METHODS AND ANALYSIS
Study setting
The HARMONY study is located in GP clinics located in 
the North West and South Eastern suburbs of Melbourne, 
Australia where the highest proportions of South Asian 
communities are located.
Eligibility criteria
Inclusion criteria: To be eligible, GP clinics must (A) 
have ≥1 South Asian bilingual/bicultural GPs and (B) 
use either of the two most common GP medical software 
programmes in Australia (Medical Director or Best Prac-
tice) and agree to have anonymised data extraction by the 
GrHanite software program from computerised medical 
records.
Exclusion criteria: clinics outside these regions, those 
without any South Asian GPs, and whose medical software 
is neither of the two most common programmes.
Interventions
Clinics randomised into the HARMONY intervention 
arm will receive:
Clinic training with an emphasis on cultural competency
We are providing culturally competent DVA training, 
whose original adult learning programme components 
were tested through our previous trials in general prac-
tice.19 21 22 Together with migrant/refugee agencies, we 
adapted these to emphasise culturally safe practice. 
Content also drew on recommendations from the WHO 
guidelines,3 and Canadian trauma informed care guide-
lines.24 This manualised programme includes offering 
clinicians culturally competent training to: identify 
DVA symptoms; ask and respond sensitively to all, but 
especially migrant/refugee women; motivational inter-
viewing; develop women- centred goals appropriate to 
women’s readiness to make change; trauma- informed 
care; discuss safety strategies; document both ethnicity 
and DVA accurately on GP routine software; and to 
warmly refer women to support services. Training also 
includes how to refer affected children (and abusive 
partners) to available services. All intervention adminis-
trative staff will be trained about patient safety and confi-
dentiality, supportive responses and culturally safe clinic 
environments.
An important aspect of the training is the co- facilita-
tion by a GP educator and a bilingual/bicultural South 
Asian DVA advocate/educator, based with and managed 
by an immigrant women’s domestic violence service.16 
The programme is now delivered fully online (See 
protocol amendment below altered because of COVID-
19) with one 90 min session for all staff focused on whole 
clinic practice and two 90 min clinical sessions, delivered 
four to 8 weeks apart. Key features of the educational 
programme include: clinical audit with feedback, online 
modules and prereading; interactive reflective exercises 
on active listening and attitudes; role play simulation and 
case discussions; use of survivor voices in videosand a 
practice readiness checklist. This programme, (accruing 
quality assurance points for the clinician) will be further 
reinforced by opportunities over the intervention year for 
two teleconference/webinar case discussions. One clini-
cian per practice, self- selecting or chosen by staff during 
training to be the formal ‘practice champion’ will main-
tain discussion about DVA in the clinic and liaise with the 
DVA advocate. The intervention commences after the 
first training session.
HARMONY bilingual bicultural DVA advocate/educator
A South Asian advocate/educator is recruited, employed 
by and located with our partner agency InTouch, Multi-
cultural Centre Against Family Violence. The advocate/
educator will continue to provide support throughout the 
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year long intervention (commencing immediately after 
the first training and for twelve months) through:
1. Fortnightly visits or zoom calls with intervention GP 
clinics for secondary consultations and to provide 
feedback at clinic meetings.
2. Providing standard DVA casework for all migrant/ref-
ugee women 18+ referred to In Touch from Harmony 
intervention clinics and referral on to other services 
for those not migrant/refugee women.
3. Provide ad hoc secondary phone consultation with in-
tervention clinicians about patient cases and referral.
4. Accurately record and feedback casework data on re-
ferral rates to intervention practices.
Comparison
Comparison clinics will receive half an hour of online 
training and reminder newsletters to better document 
ethnicity and DVA outcomes in routine software. They 
will continue to offer routine GP care for any DVA 
patients they see. At the end of the 12- month interven-
tion, comparison clinics will be offered the full training 




(1) Recorded identification of DVA among active female 
patients aged ≥18 years on routine GP software in inter-
vention versus comparison clinics. The denominator for 
this outcome and the one below will be the number of all 
active female patients ≥18 in the same time period.
(2) Number of referrals of all affected active female 
patients 18≥recorded on routine GP software and those 
recorded as received by InTouch from intervention 
clinics versus comparison clinics. N.B. We have also asked 
clinicians to record referrals to other FV agencies and 
expect that while women will be referred elsewhere, this 
will either be randomly spread or in greater proportions 
in intervention clinics as the Harmony training manual 
lists other FV agencies.
We do not plan an adjustment for multiple outcomes.
Secondary outcomes
(3) Recorded safety planning of all affected active female 
patients by GPs in intervention clinics compared with 
comparison clinics among active female patients ≥18 
experiencing DVA. Anonymised routine data for DVSP 
will be collected from medical records using the GrHanite 
software tool.
Currently, there is no way to record Safety planning 
in routine GP software. Consequently, we have designed 
and specified that GPs record DVSP as a safety planning 
code in the Diagnosis or Reason for visit in Today’s notes 
sections. GPs in both arms of the study have been asked 
to do this.
(4) Economic evaluation will estimate cost- effectiveness 
and cost–utility. Cost- effectiveness will be computed from 
a provider perspective (cost of the intervention per case 
of DVA identified, and the cost per woman referred to 
a DVA advocate). Data on the number of consultations, 
length and type of consultation will be imputed through 
extraction via the GrHanite tool. Following the approach 
taken in the economic evaluation of IRIS, we will then 
extend the cost- effectiveness analysis to report a cost–
utility analysis. This will require a Markov model, esti-
mating longer term impacts of the intervention on both 
service use and health outcomes. Probabilistic sensitivity 
analysis will be used to explore the impact of uncertainty 
on the results. These costs will predominantly be collected 
using our own study- specific forms.
The programme logic of the study and its hypotheses 
are represented below in figure 1.
Timelines
Recruitment was completed at the end of October 2020. 
All first training sessions and all comparison clinic training 
sessions were completed by the end of April 2021.
Primary outcomes of identification, referrals and 
safety planning will be extracted from routine data from 
December 2018 to December 2019 for baseline (prior to 
any training and to COVID-19), 6 months from each clin-
ic’s commencement date (following session 1), 12 months 
(intervention completion) and 15 months following 
completion of each clinic’s first training session. Inter-
vention in the majority of clinics will be completed by the 
end of 2021.
Sample size
Unfortunately, because of unreliable routine GP data 
collection on ethnicity, language or culture, there is no 
accurate way to sample only South Asian patients. We 
have, therefore, powered the study on all women and 
recruited only among clinics in areas of high South Asian 
patient populations and with one or more South Asian 
GPs. We outline below, how we are estimating the South 
Asian patient populations among each clinic and what 
the limitations of these estimates will be.
Based on our own feasibility study and IRIS outcomes,21 
we estimate that the rate of DVA identification among 
all female patients will be five women per 1000 female 
patients in the comparison arm. To detect an increase 
in the identification or referral rate to 20 women per 
1000 with 80% power and a significance level of 5%, 873 
person- years per arm is required for individual randomi-
sation. This sample size was inflated to account for the 
cluster design; assuming an intracluster coefficient of 
0.01, and any cluster size from 2000 to 3000 person- years 
per clinic (based on conservative mean size of the GP 
female populations in our feasibility study). With these 
estimations, we require 28 clinics (allowing for a 21% 
drop- out to 22 clusters).
Recruitment
To identify eligible clinics in communities with high South 
Asian populations, we first asked the state government 
partner to identify postcodes with the highest Indian 
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HARMONY Trial Logic Model 
 
Victims of family 
violence (FV) suffer 
serious health issues 
Over-representation of South 
Asian women in FV crisis 
service data & under-ID in 
general practice 
 
GPs not trained to identify & 
appropriately treat 
migrant/refugee victims of 
FV & their families 
 
Bilingual FV caseworker 
▪ co-trains clinical staff 
▪ support for intervention GPs 
(consultation & feedback) 
▪ support for migrant/refugee 
victims of FV 
 
RACGP accredited training & skills 
development for GPs: 
▪ motivational interview & trauma 
informed care 
▪ WHO LIVES woman-centred 
practice 
▪ culturally safe practice  
▪ referral pathways & FV resources 
 
Training for clinic admin staff: 
▪ safety & confidentiality 
Online FV resources 
Policymakers interested in FV, Evidence-based research in field, social & cultural acceptability of 
program in S. Asian medical community, sustainability of project 
 
Increased identification & 
disclosure from S. Asian victims 
of FV  
Improved whole-of-practice capability 
to respond to FV, maintain safety & 
confidentiality 
Improved safety & reduced FV in 
S. Asian migrant/refugee 
communities 
Increased safety planning & 
referral to support services 
































































GrHaniteTM software installed 
▪ data monitoring & collection 
 
Process Outcomes: Increasing knowledge, skills, & confidence; increasing GP readiness to practise 
with cultural competence; all practice staff able to maintain safety & confidentiality 
 
HARMONY 
whole-of-practice systems intervention 
cluster RCT (comparison=usual care) 
 
Sustainable, culturally 
safe primary care 
intervention for S. 




Figure 1 HARMONY programme logic model (see attachment). GP, general practitioner.
 on A









pen: first published as 10.1136/bm




6 Taft A, et al. BMJ Open 2021;11:e046431. doi:10.1136/bmjopen-2020-046431
Open access 
populations and also consulted SA community organi-
sations. HARMONY staff examined online website clinic 
data to identify GPs with SA names in relevant regions, 
and from the Melbourne and Monash Universities’ GP 
research networks and Primary Health Networks. We 
then faxed or emailed letters of invitation to all identi-
fied practices, followed by a phone call and an in person 
visit to further explain the study. Clinics that agreed to 
participate completed a Memorandum of Understanding 
(online supplemental file 1) and permission to install 
GrHanite. Following the GrHanite agreement, the soft-
ware was installed. Data from GPs will be collected, but 
those from nurses, psychologists and other allied health 
clinicians will not be extracted but may be among clini-
cians referring to InTouch.
Randomisation and allocation concealment
On recruitment of ≥10 clinics and GrHanite installation, 
a statistician (blind to assigned group) enters the list 
into a computer minimisation programme including a 
random component and allocates clinics to group A or B. 
Recruitment continues in blocks of 4 or more. Clinics are 
incrementally randomised in the same way until ≤28 are 
randomised. Clinics are randomised stratified1: for size 
of practice—small ≤5 doctors and large six or more and2 
SEIFA index for clinic postcode (1–5 classified as ‘lower’ 
and six or more as ‘higher’) and3 by location, where 
an equal number and size of clinic are assigned to the 
intervention (≤7 each for NW and SE) and comparison 
arms (≤7 each for NW and SE). Clinics are allocated and 
informed of their status by unblinded staff.
Blinding
HARMONY investigators, GrHanite staff and statisticians 
are blinded to the randomisation outcome of clinics. 
Harmony administration staff cannot be blinded to clinic 
status, as they are required to coordinate training in both 
arms of the study. Clinic staff are therefore not blinded 
either.
Data collection
GrHanite has been designed by University of Melbourne 
to help manage data acquisition for audit, research and 
health surveillance conforming to the highest standards of 
ethics, confidentiality and security. Prior to training, infor-
mation technology technical staff will install GrHanite 
within the clinic. GPs and all staff in both arms of the 
study are taught to enter country of birth and language 
spoken at home. GPs will record when DVA is disclosed 
(DV), when they discussed safety (DVSP) and whether 
they have made a referral (DVREF) and to whom.
GrHanite identifies all active female patients (three or 
more visits in the last 2 years) to identify eligible patients 
for the denominator.25 GrHanite will extract deidentified 
anonymised data at regular intervals to the statistician 
throughout the intervention period and for 3 months 
after the intervention finishes. At installation, GrHanite 
will extract historical data (from December 2018 to 
December 2019) from all recruited GP clinics, excluding 
patient identifiers (anonymised). These will be baseline 
data (to exclude any impact of pre- Covid training) when 
compared with data collected during and after the inter-
vention. Data on recorded referrals, DVA identification, 
patient sex, age, ethnicity, country of birth and language 
spoken at home will be extracted from clinic records in 
both study arms and forwarded to a confidential database 
managed by a statistician blinded to trial arm status, for 
cleaning and monitoring purposes.
Identification of SA women
South Asia (SA) comprises a diverse range of populations 
with a plethora of naming practices. We collected the 
surnames/family names used in India, Nepal, Afghan-
istan, Sri- Lanka, Pakistan, and Bangladesh. Staff began 
with a list of South Asian names provided from the 
InTouch database. BP (who is Nepalese) compiled an 
extensive list of Nepalese surnames, then using a range of 
web- based and informal approaches developed an exten-
sive list of other SA surnames. They also sourced exten-
sive lists from Forebears, an online database of surnames 
and genealogy information. They then consulted formal 
organisations (consulates, embassies and ethnic commu-
nity organisations across Australia) who provided feed-
back on their validity. They finalised a list of 7690 verified 
surnames from the SA countries above. There could 
be other naming practices that were not picked up by 
us during this process. Some ethnic groups may not be 
accessible through this method and we will not pick up 
SA women married to men of other countries. Many 
names were classified on more than one list and some 
names are not limited to SA countries. However, we took 
the decision to be more inclusive rather than less.
These surnames are flagged in the GrHanite software, 
so that we can estimate the overall SA patient population 
and SA women in each clinic. These data will be used to 
compare the ethnicity data recorded by clinic staff and 
to estimate intervention effectiveness in these patient 
populations.
Data analysis
A full statistical analysis plan is currently in draft. Anal-
ysis of the primary outcomes before (baseline), during 
(6 months) at the 12- month period and 3 months after will 
be conducted by a statistician blinded to allocation status 
using an intention- to- treat analysis. The denominators 
for the analysis (ie, number of active female patients per 
clinic) are also extracted over the same period. Poisson 
regression will be used to compare the intervention and 
comparison arms, with the number of documented iden-
tifications and referrals within the 12- month intervention 
period for every cluster as the independent variables. The 
same will be undertaken for safety planning. The Poisson 
regression models will include the number of active 
women ≥18 per clinic as the exposure variable and GP 
clinic as the random effect to take account of clustering. 
Models will adjust for any randomisation imbalance in key 
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factors or confounders, such as South Asian population 
per clinic. This subgroup analysis for estimated propor-
tions of South Asian women will not be generalisable or 
accurate, as we have not powered the study for SA status 
and identification methods are not rigorous. We will also 
analyse 15- month outcome data to test sustainability of 
the training.
Process evaluation
There is a large gap in evidence for effective DVA educa-
tion curricula.26 We will evaluate the clinic training with a 
pretest and post- test assessment of GP training using the 
GRIPS instrument24 and explore its impact in process eval-
uation outlined below. In order to explore critical factors 
affecting sustainability, we will embed the process evalu-
ation methods in normalisation process theory (NPT)27 
http://wwwnormalizationprocessorg/npt-toolkit/.
Interviews, semistructured around NPT concepts in 
DVA primary care work, will be conducted with clini-
cians, practice managers and administrative staff during 
and after the end of the intervention to assess interven-
tion process and impact. Bilingual interviews (translated 
and back- translated) will include: a subset of South Asian 
women referred to DVA agencies from both arms of the 
study; and a sample of GPs and reception staff in both 
arms to explore the experiences of the intervention and 
what was achieved; and key stakeholders including DVA 
advocates, In Touch managers and DVA community- 
based agencies, to explore factors influencing success or 
limitations of the model and the value to clinics. Qual-
itative data will be transcribed, entered into NVivo and 
coded and analysed according to NPT.
Ethical issues and dissemination
Harmony has an obligation to mitigate any harms from 
this study.28 We will establish a data safety monitoring 
committee (DSMC) whose role is defined as:
 ► Monitor implementation of trial protocol, safety and 
any reported harms.28
 ► Monitor clinics withdrawals and lost to follow- up.
 ► Monitor evidence for differences between the inter-
vention and comparison clinics in the main efficacy 
outcome measures and advise if discontinuation of 
the trial is necessary.
 ► Monitor continuing appropriateness of data collected 
in relation to patient information.
 ► Advise on protocol modifications, suggested by inves-
tigators (eg, to trial endpoints or sample size).
 ► Monitor sample size assumptions.
 ► Monitor compliance with previous DSMC 
recommendations.
We will be teaching clinicians self- care and how to 
manage vicarious trauma. We will also provide two GP 
teleconferences for an opportunity to discuss current 
practice with GPs and bilingual caseworkers. Additionally, 
all participating GPs will be provided with contact infor-
mation of the Doctor’s Health Advisory Service http://
www. dhas. org. au/) and the Regional Mental Health 
Service. Our hypothesis is that affected patients in inter-
vention clinics will receive enhanced GP care and patients 
in comparison clinics will receive usual care until after the 
intervention.
Data privacy
Data from electronic medical records will be extracted 
using GrHanite. This deidentifies and encrypts the 
data. Although deidentified, GrHanite employs privacy 
protecting record linkage techniques that will involve 
the extraction of limited clinical information relating to 
females aged ≥18 identified as experiencing DVA. Data 
collected from referrals received by In Touch will be 
anonymised.
Consent and confidentiality
We are obtaining consent at GP practice level. Given the 
nature of the data collected, that is, patient identifiers 
removed (deidentified), and the privacy protecting tech-
niques used by GrHanite to protect individual identity, 
consent to query the patient electronic medical records 
is sought only from the general practices, and not indi-
vidual patients. As data are deidentified, we believe the 
risk of harm to patients is negligible.
Dissemination policy
We will create summaries for participating clinics, 
short accessible policy briefs for governments, offer 
community media summaries, write peer- reviewed 
journal articles and present results to relevant national 
and international conferences.
The HARMONY study has received ethical approval 
from the La Trobe University Human Ethics Committee 
(HEC18413).
Protocol amendment
The Harmony study commenced recruitment late in 
2019, and one clinic received two sessions of face- to- 
face DVA training but had not received any advocate 
intervention, three received one session only and 
some comparison clinics the half hour training face to 
face until the COVID-19 pandemic hit Melbourne and 
was worst in recruiting areas. The study was suspended 
March to September 2020 and recommenced recruit-
ment in September 2020. All training is now online 
and the one fully trained clinic was given a brief 
refresher course. Current and future amendments 
made in ANZCTR.
DISCUSSION
Women from migrant and refugee backgrounds expe-
rience a double jeopardy from their experience of 
abuse and their migration isolation. HARMONY builds 
on learning from three previous DVA randomised 
controlled trials and guidance developed by WHO.29 
Harmony’s strengths are that it combines a system 
approach with clinic- wide strategies, DVA training for 
GPs and other clinical staff emphasising culturally 
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competency and yearlong support from bilingual/
bicultural advocates for clinicians and women to 
empower and support women from migrant/refugee 
backgrounds experiencing DVA. It may be limited 
by the fact that while the intervention is focused on 
migrant and refugee women, especially those from 
SA, the current under- recording of this in GP clinic 
data means that their proportions in clinic popu-
lations can only be a broad estimate. It is a goal of 
Harmony to improve these rates. Harmony will be a 
world- first primary care trial specifically designed 
to test culturally competent DVA primary care and 
improve routine monitoring of DVA among the diver-
sity of diaspora patients.
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